verified SJR 0,858 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · SAGE Publications Ltd

workspace_premium Q2 — Pharmacology lock Subscription

Journal of Cardiovascular Pharmacology and Therapeutics

Journal of Cardiovascular Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Cardiology and Cardiovascular Medicine with an H index of 60. It has an SJR impact factor of 0,858 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,858.

ISSN: 1074-2484

Publisher: SAGE Publications Ltd

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,858 Q2

H-index 60

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,858

H-index

Docs (year)

Docs 3y

133

Total refs

690

Cites 3y

350

Citable 3y

130

Cites/Doc 2y

3.03

Ref/Doc

40.59

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiovascular Dysfunction in Hypercholesterolemia Associated With Enhanced Formation of ATI-Receptor and of Eicosanoids

Why a New Journal in Cardiovascular Pharmacology and Therapeutics?

Deep Learning in Personalization of Cardiovascular Stents

Data-driven Decisions: The Importance of Clinical Trials in Arrhythmia Management

Conversion of Atrial Fibrillation to Sinus Rhythm During Treatment With Intravenous Esmolol or Diltiazem: A Prospective, Randomized Comparison

Comparison of Pyrroloquinoline Quinone and/or Metoprolol on Myocardial Infarct Size and Mitochondrial Damage in a Rat Model of Ischemia/Reperfusion Injury

Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis

Clustering of Acute and Subacute Stent Thrombosis Related to the Introduction of Generic Clopidogrel

Clinical Applications of Bivalirudin in the Cardiac Catheterization Laboratory

Chronic Treatment WithN-acetylcysteine Improves Cardiac Function but Does Not Prevent Progression of Cardiomyopathy in Syrian Cardiomyopathic Hamsters

Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation

Chlorthalidone Improves Endothelial-Mediated Vascular Responses in Hypertension Complicated by Nondiabetic Metabolic Syndrome

SHOW MORE ARTICLES

Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner

A Model of Blood Component-Heart Interaction in Cardiac Ischemia-Reperfusion Injury using a Langendorff-Based Ex Vivo Assay

Cardiovascular and Endothelial Effects of Fish Oil Supplementation in Healthy Volunteers

Beneficial Effects of Vitamin E Treatment in Acute Myocardial Infarction

Antihypertensive Drugs and Male Sexual Dysfunction

Antiarrhythmic Therapy of Ventricular Arrhythmias: The Contemporary Dilemma

Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan

Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of QT Dispersion to Predict Proarrhythmia

Aldosterone Antagonists in Heart Failure

Acute In Vitro Effects of Dronedarone, an Iodine-Free Derivative, and Amiodarone, on the Rabbit Sinoatrial Node Automaticity: A Comparative Study

A Systematic Review and Meta-Analysis of the Effects of Pycnogenol on Plasma Lipids

A Review of the Appropriate and Inappropriate Use of Dronedarone: Lessons Learned From Controlled Studies and Regulatory Submission

FAQs

Journal of Cardiovascular Pharmacology and Therapeutics has an SJR of 0,858 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Cardiovascular Pharmacology and Therapeutics is 30%.

Journal of Cardiovascular Pharmacology and Therapeutics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Cardiovascular Pharmacology and Therapeutics?

What is the APC / publication cost?

What is the acceptance rate?